Tonix Pharmaceuticals (TNXP) Stock Surges Following FDA Regulatory Update
After a major regulatory update, Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) saw a sharp increase in the value of its shares. TNXP shares were up 35.02% to $31.10 as of the most recent market check. The spike comes after the business revealed that TNX-102 SL, its experimental fibromyalgia therapy, is being reviewed by regulators. The …
Tonix Pharmaceuticals (TNXP) Stock Surges Following FDA Regulatory Update Read More »